![Nicholas Ventresca, SVP & CIO, ARIAD Pharmaceuticals, [NASDAQ:ARIA] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/450x308_LEtG.jpg "Nicholas Ventresca, SVP & CIO, ARIAD Pharmaceuticals, [NASDAQ:ARIA] | Life Sciences Review")
![Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/450x308_B7i0.gif "Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE] | Life Sciences Review")
![Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River [NYSE: CRL] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/450x308_53iN.jpg "Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River [NYSE: CRL] | Life Sciences Review")
![Jessica Thongcharen, Director Global Patient Safety & Evaluation- Clinical Operations, Takeda [TYO: 4502] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/15-450x308_81wP.jpg "Jessica Thongcharen, Director Global Patient Safety & Evaluation- Clinical Operations, Takeda [TYO: 4502] | Life Sciences Review")
![Rose Fida, Executive Director, Program & Performance Excellence, Global R&D Portfolio & Operations Excellence, CSL [ASX: CSL] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/Untitled-1-450x308_DOfP.jpg "Rose Fida, Executive Director, Program & Performance Excellence, Global R&D Portfolio & Operations Excellence, CSL [ASX: CSL] | Life Sciences Review")
![Yojiro Kamiya, Country Sales Director, Regeneron [NASDAQ: REGN] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/450x308_CU93.jpg "Yojiro Kamiya, Country Sales Director, Regeneron [NASDAQ: REGN] | Life Sciences Review")
![Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/39-450x308_9ez4.jpg "Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS] | Life Sciences Review")
Biosolutions R&D: Driving Meaningful Impact in the Agricultural Value Chain
Lone Baekgaard, Vice President of Animal and Plant Biosolutions R&D, Novonesis
BioRegen: Advancing Surgical Outcomes through Biomaterial Precision
Dr. Xiaozheng Shu, Founder and CEO, Andong Chen, Overseas Business Manager
Rightsource Revolutionizes Biopharma Outsourcing
Luis Berrade, Sr. Director, Global Biologics Testing Sales, & Ian Wyllie, Director, RightSource Solutions, Charles River Laboratories
Emphasizing the Importance of Assuring Product Quality
Raymond R. Tjandrawinata, Director of Business Development and Scientific Affairs, Dexa Medica
Thousand Oaks Biologics: Scaling Biologics through Integrated Manufacturing Systems
Shun Luo, Founder, Chairman and President
The simple things in life are still the best, even in clinical development
Ken Lee, General Manager and Region Head, Clinical Development, Asia Pacific, Syneos Health
Infection Detection and Management: A Huge Burden to Health Systems
Rachna DayalFounder & Managing PartnerSugati Ventures
cBioMey: Bio-Interactive Structural Delivery for Active Upgrading
Shaohua Ren, Pharmacist, CEO
Director of the Cosmetic and Reconstructive Center
Henri P. Gaboriau MDFACS, Head Of Department ENT/Facial Plastic and Reconstructive SurgeryAdirondack Health![Peter O’Callaghan, Head of Expression System Sciences, Lonza [SWX: LONN] | Life Sciences Review](https://www.lifesciencesreviewapac.com/newstransfer/upload/450x308_4hsC.jpg)
Strategies to Optimise Expression Challenges of Multi-chain and Bispecific Antibodies
Peter O’Callaghan, Head of Expression System Sciences, Lonza [SWX: LONN]
ADBIOTECH: Shift from Reactive Treatment to Proactive Immunity
Hong Gul Cheong, CEO
Intensive Care Medicine -The Original Tech Disruptor In Healthcare
Mainak Majumdar, Director, Intensive Care Services, Mercy Health Australia
Driving Innovation From Discovery To Clinical Impact At Bristol Myers Squibb
Erick Morris, Senior Director, Translational Research, Oncology, Bristol Myers Squibb
Evolving Digital Biomarkers in Clinical Trial Space
Kazuto Yamada, Senior Director, Head of Clinical Development Planning and Supervising Five R&D Functions, Otsuka Pharmaceutical
UTC Therapeutics: A Multi-Layered Immune Strategy for Hard-to-Treat Tumors
Yangbing Zhao, President and Chief Scientific Officer
